Medvi has historically been a telehealth platform offering compounded tirzepatide for weight loss, with reported monthly costs of $250 to $450. Reviews are mixed: convenience and pricing earn praise, while inconsistent follow-up and shipping reliability are common complaints. The post-shortage regulatory environment in 2025 to 2026 has tightened compounded GLP-1 access broadly, so verify the current program details before signing up.
What Medvi Offers
- Online consult with a state-licensed clinician (video or asynchronous questionnaire)
- Compounded tirzepatide prescription where legally available
- Medication shipped directly to the patient from a partnered pharmacy
- Periodic follow-up check-ins (frequency varies by plan)
- Customer support via portal messaging
Typical Pricing
| Plan / Dose | Reported Monthly Cost | Notes |
|---|---|---|
| Starter (low-dose) | $250 to $325 | Smaller dose, more frequent shipments |
| Mid-titration | $300 to $400 | Standard pricing for most programs |
| Maintenance (10 to 15 mg equivalent) | $350 to $450 | Higher concentration vials |
| Multi-month bundle | $200 to $350 effective | Discount for prepaid 3-month commitment |
Prices fluctuate. Always verify current pricing on the platform before committing.
What Positive Reviews Often Highlight
- Lower cost than self-pay brand Mounjaro or Zepbound
- Convenience of telehealth visits without doctor-office wait times
- Direct shipping from pharmacy to home
- Weight-loss results similar to brand at comparable doses
- Side-effect profile aligning with what is described in package inserts
- Response to messages within 24 to 48 hours in many cases
What Negative Reviews Often Highlight
- Slow shipping during high-demand periods
- Difficulty reaching live support for urgent side-effect questions
- Inconsistent clinician follow-up between users
- Confusion around dosing instructions on compounded vials
- Issues with refunds or cancellations
- Service changes after FDA shortage status changed
What to Verify Before Signing Up
- State pharmacy license of the dispensing pharmacy
- Clinician licensure in your state of residence
- USP 797 or 503B compliance of the compounding pharmacy
- Beyond-use date on the vial
- Sterility and potency testing documentation
- Clear pricing and cancellation terms
- Side-effect contact path (clinician messaging, urgent line)
- Current legal availability under post-shortage rules
How Compounded Tirzepatide Works the Same as Brand
The active molecule is the same. When a compounding pharmacy uses pharmaceutical-grade tirzepatide active ingredient and proper sterility processes, the clinical effects mirror brand Mounjaro and Zepbound:
- Slows gastric emptying
- Reduces appetite via central nervous system pathways
- Improves insulin sensitivity
- Targets both GIP and GLP-1 receptors
- Produces 12 to 22 percent weight loss at full dose over 12 to 18 months on average
Common Side Effects (Same as Brand)
- Nausea (especially first 1 to 2 weeks of each dose step)
- Constipation or diarrhea
- Reflux, burping
- Decreased appetite (intended effect)
- Fatigue (usually fades)
- Injection site reactions (mild redness, bumps)
- Rare: pancreatitis, gallbladder issues
What to Bring to Your Telehealth Visit
- Recent weight and height
- Prior weight-loss attempts
- Existing medical conditions and medications
- Allergy history
- Family history of medullary thyroid carcinoma or MEN-2 (contraindications)
- Pregnancy plans
- Recent labs if available (A1C, lipids, kidney and liver function)
Reasonable Expectations
| Time | Expected Progress |
|---|---|
| Weeks 1 to 4 (2.5 mg equivalent) | Side-effect adaptation, 1 to 4 lbs loss |
| Weeks 5 to 8 (5 mg equivalent) | Cumulative 4 to 10 lbs, appetite firmly reduced |
| Weeks 9 to 16 (7.5 to 10 mg equivalent) | Cumulative 8 to 20 lbs, body composition shifts |
| Months 4 to 12 (full dose) | 10 to 22 percent total body weight reduction average |
Red Flags Across Telehealth GLP-1 Reviews
- Headline pricing well below market (under $150 monthly for compounded)
- No prescription required claim
- Ships from outside the United States
- No clinician interaction at any stage
- Pharmacy not findable on state board lookup
- Vials arriving without manufacturer/pharmacy labels
- Customer support only via cryptocurrency or wire transfer
Related Reading
For more on telehealth GLP-1 options and compounded versus brand context, see our guides on treatment options and prediabetes basics.
The Bottom Line
Medvi tirzepatide reviews paint a typical telehealth-compounded GLP-1 picture: competitive pricing, convenient online flow, and effects similar to brand tirzepatide when the compounded product is properly made — but variable customer support and shipping reliability. The post-shortage regulatory landscape has tightened compounded GLP-1 access broadly, so check current legal availability for your state. Verify the dispensing pharmacy’s state license, USP compliance, and clinician credentials. Expect the same titration schedule, side-effect timeline, and weight-loss trajectory as brand Mounjaro or Zepbound at the same effective dose.
